Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2013
04/23/2013US8426142 IgA nephropathy testing method and test kit
04/23/2013US8426141 Methods for increasing the therapeutic efficacy of immunoglobulin G class 3 (IgG3) antibodies
04/23/2013US8426140 Method of assessing colorectal cancer status in an individual
04/23/2013US8426139 Polypeptides for identifying in vitro and preventing staphyloccocal infections on joint prostheses and other implanted foreign materials
04/23/2013US8426138 Detection of sub-cellular compartment localization of a molecule using a reduced affinity enzyme complementation reporter system
04/23/2013US8426131 Method for screening candidate compounds for antitumor drug
04/23/2013US8426077 Proton conductors
04/23/2013US8425996 Indicators for detecting the presence of metabolic byproducts from microorganisms
04/23/2013US8425877 Method for diagnosis of systemic sclerosis involving an anti-AT1-receptor antibody
04/23/2013US8425864 Apparatus for transporting biological samples
04/23/2013US8425863 Micro fluidic device
04/23/2013US8425845 Genetic analysis LOC with hybridization array with calibration chamber containing probe that lacks a reporter
04/23/2013US8425844 Detection apparatus for biological materials and methods of making and using the same
04/23/2013US8425843 Integrated apparatus and method to detect inflammatory states present in a sample of whole blood
04/23/2013US8425841 Analyzing instrument
04/23/2013US8425840 Microchip and blood monitoring device
04/23/2013US8425839 First & second reagent containers, each having a record section that contains reagent management information with an information reader; section for registering information from both containers; measurement section that responds to information received; and a processing section; hematology, immunoassay
04/23/2013US8425770 Methods and compositions for chromatography
04/23/2013US8425759 Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times
04/23/2013US8425758 Small volume in vitro analyte sensor and methods of making
04/23/2013US8425743 Small volume in vitro analyte sensor and methods of making
04/23/2013DE202013101439U1 Optische Multiplex-Anordnung Optical multiplexing arrangement
04/23/2013DE202013101424U1 Elektrochemische Testplatte mit Hämofilterfunktion Electrochemical test plate with Hämofilterfunktion
04/23/2013CA2738926C Correlating push force and stalk vibration to a plant's susceptibility to root lodging
04/23/2013CA2738854C Hand-held device for measuring an analyte concentration in a sample of a body liquid
04/23/2013CA2718333C Fluorescence quencher molecules as well as methods and uses involving the same
04/23/2013CA2626532C Biochip with channel-defining protection film
04/23/2013CA2544972C Use of interleukin-22 as a biomarker of resistance to hiv infections in humans and biological applications thereof
04/23/2013CA2538604C Methods and apparatus for breath alcohol testing
04/23/2013CA2504818C Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
04/23/2013CA2493081C Reagents and methods for engaging unique clonotypic lymphocyte receptors
04/23/2013CA2451637C Liver engrafting cells, assays, and uses thereof
04/23/2013CA2422890C Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
04/23/2013CA2416761C Method for screening peptides for use in immunotherapy
04/23/2013CA2400838C Novel method for down-regulation of amyloid
04/19/2013CA2792056A1 Sample chamber for laser ablation analysis of fluid inclusions and analyzing device thereof
04/18/2013WO2013056252A1 Assessment of oocyte competence by detecting spsb2 and/or tp53i3 gene expression
04/18/2013WO2013056211A2 Telomerase reverse transcriptase deficience as diagnostic marker of myelodysplastic syndrome
04/18/2013WO2013056184A1 Cancer stem cell prognostication systems (cps)
04/18/2013WO2013056182A1 Piezoelectric devices and methods
04/18/2013WO2013056174A1 Xenograft model of human bone metastatic prostate cancer
04/18/2013WO2013056122A1 Engineered outer domain (eod) of hv gp120 and mutants thereof
04/18/2013WO2013056090A1 Affinity-based materials for the non-destructive separation and recovery of cells
04/18/2013WO2013055954A1 Biomarker for abdominal aortic aneurysm
04/18/2013WO2013055829A1 Proximity-based assays for the detection of signaling protein expression and activation
04/18/2013WO2013055811A1 Ex vivo methods of predicting responsiveness of a subject to interferon therapy
04/18/2013WO2013055799A1 Biomarker for detecting cancer
04/18/2013WO2013055791A1 Polymeric nanoparticles for ultrasound imaging and therapy
04/18/2013WO2013055780A1 Multiplexed kinase inhibitor beads and uses thereof
04/18/2013WO2013055704A1 Systems and methods for mapping new patient information to historic outcomes for treatment assistance
04/18/2013WO2013055281A1 Multi-channel flowcell
04/18/2013WO2013055142A2 Method for manufacturing multi-functional bio-material conjugate using two kinds of particle, and multi-functional bio-material conjugate manufactured by means of same
04/18/2013WO2013055101A1 Method for screening an agent preventing or treating cancer using glycyl-trna synthetase and cadherin
04/18/2013WO2013054984A1 Composition for diagnosis of lung cancer and diagnosis kit of lung cancer
04/18/2013WO2013054952A1 Indicator for determining temperature history and method for determining temperature history
04/18/2013WO2013054949A1 Chimeric non-human animal carrying human hepatocyte
04/18/2013WO2013054885A1 Methylglyoxal accumulation method, methylglyoxal measurement method, methylglyoxal accumulation animal model and method for producing same, and screening method
04/18/2013WO2013054534A1 DRUGS FOR DISEASES ASSOCIATED WITH AMYLOID β, AND SCREENING THEREFOR
04/18/2013WO2013054331A1 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
04/18/2013WO2013054311A1 Nanoscale motion detector
04/18/2013WO2013054281A1 Method to diagnose the presence of prostate cancer
04/18/2013WO2013054230A2 Method for detection of coagulation activity and biomarkers.
04/18/2013WO2013054002A1 Prevention and diagnosis of visceral fat
04/18/2013WO2013054001A1 Raising and diagnosing of serotonin level
04/18/2013WO2013053969A1 Haptens, conjugates and antibodies for the fungicide cyprodinil
04/18/2013WO2013053954A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases
04/18/2013WO2013053953A1 Method for measuring beta-lactam antibiotics
04/18/2013WO2013053921A1 Vessel mapping apparatuses and methods
04/18/2013WO2013053919A2 Biomarkers of renal disorders
04/18/2013WO2013053918A1 Diagnosis of intraocular lymphoma
04/18/2013WO2013053916A1 Procathepsin l and cathepsin l as biomarkers for ischemia
04/18/2013WO2013053901A1 METHOD FOR DETECTION OF Gα15 AS TUMOR MARKER IN PANCREATIC CANCER
04/18/2013WO2013053894A1 Methods and kits for detecting cardiac remodeling in subjects without clinical signs of heart failure
04/18/2013WO2013053741A1 Anti-spla2-v antibodies and uses thereof
04/18/2013WO2013053698A1 Method for determining the interaction between a polynucleotide and blood platelet factor 4
04/18/2013WO2013053694A1 Monoclonal anti-idiotype antibody ganglidiomab
04/18/2013WO2013053641A1 Allergens from insects
04/18/2013WO2013053624A1 Method for increasing the immunity of a fire detector to false alarms
04/18/2013WO2013053578A1 Method and use for detecting a part of interest in biological samples
04/18/2013WO2013053513A1 Device and method for parallel recording of impedance spectra and field potential
04/18/2013WO2013053359A1 Diagnostic and prognostic use of prombp-complexes
04/18/2013WO2013053065A1 Methods and kits for diagnosing and/or prognosing osteoarthritis
04/18/2013WO2013053039A1 Microfluidic reconfigurable device for multi-plexed sample analysis
04/18/2013WO2013053023A1 Preparation of samples for analysis
04/18/2013WO2013028070A3 Compounds for use in boosting coagulation
04/18/2013WO2013026576A3 Cholesterol oxidase
04/18/2013WO2013022789A3 Compositions and methods for assessing and determining the presence of liver cancer in a mammalian subject
04/18/2013WO2013022786A3 Microrna biomarkers
04/18/2013WO2013017891A3 Assay
04/18/2013WO2013016600A3 Methods for diagnosing cancer by characterization of tumor cells associated with pleural or serous fluids
04/18/2013WO2013016106A3 Glass sampling apparatus and method for using same to obtain a glass sample from a glass melting vessel
04/18/2013WO2012164026A8 Methods for diagnosing multiple sclerosis
04/18/2013WO2012151390A3 A therapeutic and diagnostic target gene in acute myeloid leukemia
04/18/2013WO2012065095A3 Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
04/18/2013US20130096846 Automated blood analyzer
04/18/2013US20130096842 Glucose tolerance analyzer, glucose tolerance analyzing system, and storage medium
04/18/2013US20130096533 Tissue penetration device
04/18/2013US20130096072 Zymogen Activators
04/18/2013US20130096052 Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
04/18/2013US20130096030 Multisensor array for detection of analytes or mixtures thereof in gas or liquid phase